The value of companies goes up to the sky after the news about the anti-Convidian vaccine

The shares of German-based companies BioNTech SE BNTX and Pfizer Inc have danced sharply in the stock market during today, immediately after news of the success of the candidate vaccine for Covid-19. One was raised by 23.4 percent, while the other for 11.5 percent, according to MarketWatch, broadcast Periscope. These [...]
One was raised by 23.4 percent, while the other for 11.5 percent, according to MarketWatch, broadcast Periscope.
These are just the first internal tests of Stage Three.
Companies said the BNT162b2 candidate vaccine was found to have been more than 90% effective in preventing Covid-19 in testing participants who had no evidence to have been infected with SARS-CoV-2.
These companies added that they planned to apply for Authorised Emergency Use (EUA) to the Food and Drug Administration (FDA) immediately after security tests are implemented, which defines the third week of November as opportunities.
“Today is a big day for science and humanity,” said Pfizer Chief Executive Chief Dr. Albert Bourla.
The first test of the results from the Third phase of the Cavid-19 shows that the initial evidence of our vaccine and its ability to prevent Avid-19s. ” /Periscope












